EUVIMEDEUVIMED entdecken
Crossref

Empagliflozin Nano-cocrystals with Citric and Ascorbic Acids: A Cocrystal Nanonization Strategy for Modulation of Solubility, Permeability, Flowability, Pharmacodynamic Effect and Stability

Gulzaib Zafar, Hafsa Afzal, Nadeem Irfan Bukhari, Misbah Hameed, Sairah Hafeez Kamran, Qazi Amir Ijaz, Sumera Latif

Journal of Pharmaceutical Innovation · 2027-02 · 22 (1)

DOI: 10.1007/s12247-026-11151-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Innovation, online erschienen am 19.11.2026. Verfasst von Gulzaib Zafar und 6 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zafar, G., Afzal, H., Bukhari, N. I., Hameed, M., Kamran, S. H., Ijaz, Q. A., & Latif, S. (2027). Empagliflozin Nano-cocrystals with Citric and Ascorbic Acids: A Cocrystal Nanonization Strategy for Modulation of Solubility, Permeability, Flowability, Pharmacodynamic Effect and Stability. Journal of Pharmaceutical Innovation, 22(1). https://doi.org/10.1007/s12247-026-11151-3

Vancouver

Zafar G, Afzal H, Bukhari NI, Hameed M, Kamran SH, Ijaz QA, et al. Empagliflozin Nano-cocrystals with Citric and Ascorbic Acids: A Cocrystal Nanonization Strategy for Modulation of Solubility, Permeability, Flowability, Pharmacodynamic Effect and Stability. Journal of Pharmaceutical Innovation. 2027;22(1). doi:10.1007/s12247-026-11151-3

BibTeX
@article{Zafar2027,
  author = {Zafar, Gulzaib and Afzal, Hafsa and Bukhari, Nadeem Irfan and Hameed, Misbah and Kamran, Sairah Hafeez and Ijaz, Qazi Amir and Latif, Sumera},
  title = {Empagliflozin Nano-cocrystals with Citric and Ascorbic Acids: A Cocrystal Nanonization Strategy for Modulation of Solubility, Permeability, Flowability, Pharmacodynamic Effect and Stability},
  journal = {Journal of Pharmaceutical Innovation},
  year = {2027},
  volume = {22},
  number = {1},
  doi = {10.1007/s12247-026-11151-3}
}
Kostenlos starten →